These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23972039)

  • 1. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial.
    Wedemeyer H; Schöneweis K; Bogomolov P; Blank A; Voronkova N; Stepanova T; Sagalova O; Chulanov V; Osipenko M; Morozov V; Geyvandova N; Sleptsova S; Bakulin IG; Khaertynova I; Rusanova M; Pathil A; Merle U; Bremer B; Allweiss L; Lempp FA; Port K; Haag M; Schwab M; Zur Wiesch JS; Cornberg M; Haefeli WE; Dandri M; Alexandrov A; Urban S
    Lancet Infect Dis; 2023 Jan; 23(1):117-129. PubMed ID: 36113537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.
    Havens PL; Hazra R; Stephensen CB; Kiser JJ; Flynn PM; Wilson CM; Rutledge B; Bethel J; Pan CG; Woodhouse LR; Van Loan MD; Liu N; Lujan-Zilbermann J; Baker A; Kapogiannis BG; Gordon CM; Mulligan K;
    Antivir Ther; 2014; 19(6):613-8. PubMed ID: 24535626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
    Anastasiou OE; Caruntu FA; Curescu MG; Yalcin K; Akarca US; Gürel S; Zeuzem S; Erhardt A; Lüth S; Papatheodoridis GV; Keskin O; Port K; Radu M; Celen MK; Idilman R; Heidrich B; Mederacke I; von der Leyen H; Kahlhöfer J; von Karpowitz M; Hardtke S; Cornberg M; Yurdaydin C; Wedemeyer H
    Liver Int; 2024 Jan; 44(1):139-147. PubMed ID: 37787009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.
    de Lédinghen V; Fougerou-Leurent C; Le Pabic E; Pol S; Alfaiate D; Lacombe K; Hilleret MN; Lascoux-Combe C; Minello A; Billaud E; Rosa I; Gervais A; Ratziu V; Ganne N; Pageaux GP; Leroy V; Loustaud-Ratti V; Mathurin P; Chas J; Jezequel C; Métivier S; Dumortier J; Arpurt JP; Asselah T; Roche B; Le Gruyer A; Valantin MA; Scholtès C; Gordien E; Tual C; Kortebi A; Coulibaly F; Rosenthal E; Subic-Levrero M; Roulot D; Zoulim F;
    JHEP Rep; 2024 Aug; 6(8):101057. PubMed ID: 39045338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies.
    Patmore LA; van der Eijk AA; Janssen HLA; de Man RA; Sonneveld MJ
    J Hepatol; 2024 Jul; 81(1):e49-e50. PubMed ID: 38036005
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to: "Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies".
    Ricco G; Brunetto MR
    J Hepatol; 2024 Jul; 81(1):e51-e53. PubMed ID: 38582305
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delta hepatitis in Africa: epidemiological and clinical particularities].
    Lunel Fabiani F; El Bara A; Hamed CT; LE Guillou Guillemette H
    Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana.
    Baruti K; Phinius BB; Phakedi B; Mpebe G; Choga W; Bhebhe L; Mulenga G; Moraka NO; Ratsoma T; Pretorius-Holme M; Makhema J; Shapiro R; Lockman S; Moyo S; Jongman M; Anderson M; Gaseitsiwe S
    J Infect Public Health; 2023 Nov; 16(11):1736-1741. PubMed ID: 37734129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection.
    Begré L; Béguelin C; Boyd A; Peters L; Rockstroh J; Günthard HF; Bernasconi E; Cavassini M; Lacombe K; Mocroft A; Wandeler G; Rauch A
    Front Med (Lausanne); 2022; 9():988356. PubMed ID: 36186807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy.
    Brancaccio G; Shanyinde M; Puoti M; Gaeta GB; Monforte AD; Vergori A; Rusconi S; Mazzarelli A; Castagna A; Antinori A; Cozzi-Lepri A;
    Pathog Glob Health; 2023 Mar; 117(2):181-189. PubMed ID: 35249472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
    Hayashi T; Takeshita Y; Hutin YJ; Harmanci H; Easterbrook P; Hess S; van Holten J; Oru EO; Kaneko S; Yurdaydin C; Bulterys M
    Arch Public Health; 2021 Oct; 79(1):180. PubMed ID: 34663473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study.
    Boyd A; Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Gozlan J; Zoulim F; Delaugerre C; Rougier H; Lacombe K
    JMIR Res Protoc; 2021 Apr; 10(4):e24731. PubMed ID: 33821807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
    Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
    BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients.
    Boyd A; Miailhes P; Brichler S; Scholtès C; Maylin S; Delaugerre C; Chevallier-Queyron P; Gordien E; Girard PM; Lacombe K
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1535-40. PubMed ID: 23972039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate.
    Lacombe K; Gozlan J; Boelle PY; Serfaty L; Zoulim F; Valleron AJ; Girard PM
    AIDS; 2005 Jun; 19(9):907-15. PubMed ID: 15905671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
    Boyd A; Gozlan J; Maylin S; Delaugerre C; Peytavin G; Girard PM; Zoulim F; Lacombe K
    Hepatology; 2014 Aug; 60(2):497-507. PubMed ID: 24752996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
    Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M
    J Viral Hepat; 2012 Nov; 19(11):801-10. PubMed ID: 23043387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.